| Bioactivity | OsMo is a lysosome-targeting hNEU1 inhibitor that can be used in the study of myocardial injury[1]. |
| Formula | C20H35N3O5 |
| Molar Mass | 397.51 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Zhou W, et al. A Lysosome-Targeting hNEU1 Inhibitor Treats Myocardial Infarction: A Potential Therapeutic Breakthrough. J Med Chem. 2024 Sep 26;67(18):16899-16911. |